Yield10 Bioscience (YTEN)

P/S ratio as of December 2024 (TTM): 0.4265

According to Yield10 Bioscience's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -0.0554. At the end of 2024 the company had a P/S ratio of 0.9519.

P/S ratio history for Yield10 Bioscience from 2006 to 2024

PS ratio at the end of each year

Year	P/S ratio	Change
2024	0.9519	-98.01%
2023	47.8	96.25%
2022	24.3	-37.76%
2021	39.1	62.19%
2020	24.1	203.59%
2019	7.94	-46.92%
2018	15.0	-6.99%
2017	16.1	88%
2016	8.56	-55.02%
2015	19.0	-4.25%
2014	19.9	135.71%
2013	8.43	602.65%
2012	1.20	-98.9%
2011	109	-85.09%
2010	731	255.36%
2009	206	9.46%
2008	188	-31.48%
2007	274	242.43%
2006	80.0

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
NRC Health NRC	2.79	554.86%	🇺🇸 USA
Nymox Pharmaceutical NYMX	N/A	N/A	Bahamas

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Yield10 Bioscience (YTEN)

P/S ratio as of December 2024 (TTM): 0.4265